Bionor Pharma chosen as one of the Top 10 Infectious Disease Projects to Watch
All the Top 10 companies are invited to present their projects at Windhover’s Therapeutic Area Partnerships meeting in Boston, 18-20 November 2013.
Oslo 26.07.2013 - The announcement of the selection of Bionor Pharma included: “The publishers of In Vivo, Startup and The
Pink Sheet are pleased to announce that your Vacc-4x/Vacc-C5 have been chosen as one of the Top 10 Infectious Disease Projects
to Watch. This represents a significant industry honor. Many of our past top 10 include those who partnered successfully
such as Trophos, BiPar, Myogen, Sirtris and Kosan. Bionor is invited to present at Windhover’s Therapeutic Area Partnerships
meeting taking place on November 18-20, 2013 at the Hyatt Regency Boston (www.tapartnerships.com)”